Company Data

BioAtla Inc.

Ticker
BCAB
Current Price
$0.4486 -4.25%
Market Cap
$21.7M
Price Target
Refer to Report
Volume
335.0K
52wk Range
$0.38 - $4.02
Advanced Market Data

Overview

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise Mecbotamab vedotin, Ozuriftabmab vedotin, BA3071, and Bispecific antibody programs.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy